Integrated approaches for immunotoxicity risk assessment: challenges and future directions
Discover Toxicology · 2024
DOI: 10.1007/s44339-024-00010-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Toxicology, 2024. Verfasst von Vaisali Chandrasekar und 11 weiteren Autor:innen. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The integration of immunotoxicity data into chemical risk assessment paradigms is essential for comprehensively evaluating the potential health hazards posed by chemical exposures. This review provides a comprehensive overview of the methodologies, challenges, and future directions for integrating immunotoxicity data into risk assessment frameworks. It discusses the fundamental principles of immunotoxicology and its relevance to chemical risk assessment, highlighting the critical roles of the immune system in health and defense against harmful agents. Next, we explore traditional chemical risk assessment frameworks, including exposure assessment, hazard identification, dose–response assessment, and risk characterization, highlighting the need for incorporating immunotoxicity endpoints to enhance hazard characterization and risk estimation. Subsequently, we delve into dose–response modelling for immunotoxicity, elucidating principles, methods, and case studies illustrating dose–response relationships and extrapolation of data from animal studies to humans. Furthermore, we discuss hazard characterization of immunotoxicity, focusing on the identification of immunotoxic hazards, evaluation of immunotoxicity endpoints, and utilization of immunological biomarkers in risk assessment. We then examine cumulative risk assessment strategies, presenting a conceptual framework for assessing cumulative risks of immunotoxicity from multiple chemical exposures and methods for integrating exposure and hazard data from different chemicals. Lastly, we explore emerging trends and future directions in immunotoxicity risk assessment, including high-throughput screening assays, omics technologies, computational modelling, and alternative testing methods, along with potential regulatory implications and future research needs. This review provides valuable insights for researchers, regulators, and stakeholders involved in chemical risk assessment and public health protection, facilitating the development of evidence-based strategies for safeguarding human health from immunotoxic risks associated with chemical exposures.
Zitieren
APA
Chandrasekar, V., Panicker, A. J., Dey, A. K., Mohammad, S., Chakraborty, A., Samal, S. K., Dash, A., Bhadra, J., Suar, M., Khare, M., Dakua, S. P., & Singh, A. V. (2024). Integrated approaches for immunotoxicity risk assessment: challenges and future directions. Discover Toxicology. https://doi.org/10.1007/s44339-024-00010-w
Vancouver
Chandrasekar V, Panicker AJ, Dey AK, Mohammad S, Chakraborty A, Samal SK, et al. Integrated approaches for immunotoxicity risk assessment: challenges and future directions. Discover Toxicology. 2024. doi:10.1007/s44339-024-00010-w
BibTeX
@article{Chandrasekar2024,
author = {Chandrasekar, Vaisali and Panicker, Anu Jayanthi and Dey, Arindam K and Mohammad, Syed and Chakraborty, Aparajita and Samal, Shailesh Kumar and Dash, Alisha and Bhadra, Jolly and Suar, Mrutunjay and Khare, Manish and Dakua, Sarada Prasad and Singh, Ajay Vikram},
title = {Integrated approaches for immunotoxicity risk assessment: challenges and future directions},
journal = {Discover Toxicology},
year = {2024},
doi = {10.1007/s44339-024-00010-w}
}
EUVIMED